losing muscle mass on semaglutide GLP-1 and Loss: Semaglutide, Tirzepatide & Lean Woman shares what happened after

The core principle involves front-loading nutrition

Our urgency reflects the reality of the market, and our customers benefit from that focus

In patients with mCRPC whose disease progressed during or after treatment with docetaxel, cabazitaxel was shown to improve survival compared with mitoxantrone in a randomized trial (NCT00417079).[65] In this trial, 755 such men were treated with prednisone (10 mg PO qd) and randomly assigned to receive either cabazitaxel (25 mg/m2 IV) or mitoxantrone (12 mg/m2 IV) every 3 weeks.[65][Level of evidence A1] Median OS was 15.1 months in the cabazitaxel arm and 12.7 months in the mitoxantrone study arm (HR death, 0.70

Ben: I'll give you a hint